Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review

Esophageal cancer (EC) has the seventh highest incidence and the sixth highest mortality rate of any type of cancer worldwide. In China, esophageal squamous cell carcinoma (ESCC) accounts for more than 95% of EC patients. The main treatment for EC patients is surgery and/or chemoradiotherapy (CRT)....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wencheng, Wang, Ping, Pang, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576075/
https://www.ncbi.nlm.nih.gov/pubmed/33241042
http://dx.doi.org/10.21037/atm-20-4625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576075/
https://www.ncbi.nlm.nih.gov/pubmed/33241042
http://dx.doi.org/10.21037/atm-20-4625

Ejemplares similares